scholarly journals Role of insulin receptor substrate-1 for diethylnitrosamine plus high-fat diet-induced hepatic tumorigenesis in mice

2013 ◽  
Vol 5 (1) ◽  
pp. 27-30 ◽  
Author(s):  
Khadbaatar Zolzaya ◽  
Akinobu Nakamura ◽  
Kazuki Tajima ◽  
Yasuo Terauchi
Hypertension ◽  
2014 ◽  
Vol 64 (suppl_1) ◽  
Author(s):  
Shuang-Quan Yu ◽  
Donna H Wang

Metformin, an anti-type 2 diabetic agent that increases insulin sensitivity in target tissues, has been suggested having neuroprotective effects. Our previous data showed that metformin protects against high fat diet (HFD)-induced impairment in renal afferent nerves that express the transient receptor potential vanilloid 1 (TRPV1) channels, and prevents HFD-induced renal functional deterioration and hypertension. However, mechanisms of metformin-mediated neuroprotection are largely unknown. This study tests the hypothesis that HFD impairs insulin signaling in afferent renal nerves, which is prevented by metformin via the pathway of IRS-1-tyr, AMPK, and GLUT-1/3. Metformin (1 ng/kg, daily intrathecal injection via indwelled catheters to segments T8-L3 supplying the kidneys) or vehicle was given to rats fed a HFD or normal fat diet (Con) for 8 weeks. Immunohistochemical staining showed that insulin receptor substrate-1 phosphorylated with serine (p-IRS-1-ser), insulin receptor substrate-1 phosphorylated with tyrosine (p-IRS-1-tyr), phosphorylated AMP-activated protein kinase (p-AMPK), glucose transporter 1 (GLUT-1), and GLUT-3 were expressed in dorsal root ganglia (DRG). Levels of p-IRS-1-ser were increased by HFD but decreased by metformin in Con rats, and HFD-induced increases in p-IRS-1-ser were prevented by metformin. Levels of p-IRS-1-tyr, p-AMPK, and the trafficking of GLUT-1 and GLUT-3 from cytoplasma to cell membrane in DRG were decreased by HFD but increased by metformin in Con rats, and HFD-induced decreases in these parameters were prevented by metformin (p-IRS-1-tyr, Con: 0.23±0.02, Con+Met: 0.34±0.04, HFD: 0.14±0.02, HFD+Met: 0.22±0.03, p<0.05). Afferent renal nerve activity (ARNA) in response to insulin perfusion into the renal pelvis was decreased by HFD but enhanced by metformin in Con rats, and HFD-induced decreases in ARNA was prevented by metformin. Our data showed that HFD decreases insulin signaling in afferent renal nerves, which is prevented by metformin injected intrathecally to segments innervating kidneys. These data indicate that metformin may constitute neuroprotecitve effects via improving insulin signaling in afferent renal nerves via activation of the pathway of IRS-1-tyr, AMPK, and GLUT-1/3.


Metabolism ◽  
2018 ◽  
Vol 85 ◽  
pp. 48-58 ◽  
Author(s):  
Naoyuki Kitao ◽  
Akinobu Nakamura ◽  
Hideaki Miyoshi ◽  
Hiroshi Nomoto ◽  
Kiyohiko Takahashi ◽  
...  

2016 ◽  
Vol 31 (1) ◽  
pp. 68-72 ◽  
Author(s):  
Touraj Mahmoudi ◽  
Keivan Majidzadeh-A ◽  
Khatoon Karimi ◽  
Hamid Farahani ◽  
Reza Dabiri ◽  
...  

Background Given the major role of obesity and insulin resistance (IR) in colorectal cancer (CRC), we investigated whether genetic variants in ghrelin ( GHRL), resistin ( RETN) and insulin receptor substrate 1 ( IRS1) were associated with CRC risk. Methods This study was conducted as a case-control study, and 750 subjects, including 438 controls and 312 patients with CRC, were enrolled and genotyped using the PCR-RFLP method. Results No significant differences were observed for GHRL (rs696217), RETN (rs3745367) and IRS1 (rs1801278, Gly972Arg or G972R) gene variants between the cases and controls. However, the IRS1 G972R R allele compared with the G allele and the G972R RR+GR genotype compared with the GG genotype appeared to be markers of decreased CRC susceptibility in the overweight/obese subjects (p = 0.024; odds ratio [OR] = 0.42, 95% confidence interval [95% CI], 0.20-0.91; and p = 0.048; OR = 0.42, 95% CI, 0.17-0.99, respectively). Furthermore, the R allele and RR+GR genotype were also associated with decreased risks for obesity in the patients with CRC (p = 0.007; OR = 0.35, 95% CI, 0.15-0.77; and p = 0.015; OR = 0.35, 95% CI, 0.15-0.72, respectively). Conclusions In accordance with previous studies, our findings suggest that the IRS1 G972R R allele and RR+GR genotype have protective effects for CRC in overweight/obese patients and for obesity in patients with CRC. Nevertheless, further studies are required to confirm these findings.


2002 ◽  
Vol 16 (3) ◽  
pp. 552-562 ◽  
Author(s):  
Xiaoqin Xiang ◽  
Mingsheng Yuan ◽  
Ying Song ◽  
Neil Ruderman ◽  
Rong Wen ◽  
...  

Abstract The appearance of a complex between tyrosine-phosphorylated insulin receptor substrate 1 (IRS-1) and PI3K in a high-speed pellet fraction (HSP) is thought to be a key event in insulin action. Conversely, the disappearance of the IRS-1/PI3K complex from this fraction has been linked to insulin desensitization. The present study examines the role of 14-3-3, a specific phospho-serine binding protein, in mediating the disappearance of IRS-1 from the HSP after insulin treatment. An in vitro pull-down assay using recombinant 14-3-3 revealed that insulin enhances the association of 14-3-3 with IRS-1 in cultured adipocytes and that this is completely inhibited by wortmannin. An association of IRS-1 and 14-3-3 was also observed and was maximal after stimulation by insulin, when endogenous proteins were immunoprecipitated. Epidermal growth factor (EGF), 12-O-tetradecanoylphorbol-13-acetate, and okadaic acid, other agents that cause serine/threonine phosphorylation of IRS-1, also stimulated IRS binding to 14-3-3. The enhancement of IRS-1 binding to 14-3-3 by insulin was accompanied by movement of IRS-1 and the p85 subunit of PI3K from the HSP to the cytosol. In keeping with a key role of 14-3-3 in mediating this redistribution of IRS-1, the complexes of IRS-1 and 14-3-3 were found in the cytosol but not in the HSP of insulin-treated cells. In addition, colocalization of IRS-1 and 14-3-3 was observed in the cytoplasm after insulin treatment by confocal microscopy. Finally, the addition of a phosphorylated 14-3-3 binding peptide to an adipocyte homogenate (to remove 14-3-3 from IRS-1) increased the abundance of IRS-1/PI3K complexes in the HSP and decreased their abundance in the cytosol. These findings strongly suggest that 14-3-3 participates in the intracellular trafficking of IRS-1 by promoting the displacement of serine-phosphorylated IRS-1 from particular structures. They also suggest that 14-3-3 proteins could play an integral role in the process of insulin desensitization.


2003 ◽  
Vol 23 (21) ◽  
pp. 7510-7524 ◽  
Author(s):  
Joanna Trojanek ◽  
Thu Ho ◽  
Luis Del Valle ◽  
Michal Nowicki ◽  
Jin Ying Wang ◽  
...  

ABSTRACT The receptor for insulin-like growth factor I (IGF-IR) controls normal and pathological growth of cells. DNA repair pathways represent an unexplored target through which the IGF-IR signaling system might support pathological growth leading to cellular transformation. However, this study demonstrates that IGF-I stimulation supports homologous recombination-directed DNA repair (HRR). This effect involves an interaction between Rad51 and the major IGF-IR signaling molecule, insulin receptor substrate 1 (IRS-1). The binding occurs within the cytoplasm, engages the N-terminal domain of IRS-1, and is attenuated by IGF-I-mediated IRS-1 tyrosine phosphorylation. In the absence of IGF-I stimulation, or if mutated IGF-IR fails to phosphorylate IRS-1, localization of Rad51 to the sites of damaged DNA is diminished. These results point to a direct role of IRS-1 in HRR and suggest a novel role for the IGF-IR/IRS-1 axis in supporting the stability of the genome.


1997 ◽  
Vol 272 (41) ◽  
pp. 25839-25844 ◽  
Author(s):  
Yasushi Kaburagi ◽  
Shinobu Satoh ◽  
Hiroyuki Tamemoto ◽  
Ritsuko Yamamoto-Honda ◽  
Kazuyuki Tobe ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document